Introduces New Liquid Handling Solutions to Provide Real-Time and Future Adaptability in Throughput, Capacity and Dynamic Volume Range
BOSTON, MA -- January 23, 2006 -- PerkinElmer Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced extensive new capabilities for its comprehensive JANUS™ Automated Workstation platform at LabAutomation 2006, in Palm Springs, California, booth #339. The single JANUS platform includes new features and functionalities to provide laboratories with real-time and future adaptability in throughput, capacity and dynamic volume range to meet their liquid handling automation needs.
JANUS is the cornerstone of PerkinElmer’s Packard Automation and Liquid Handling Portfolio, its next generation of automation and liquid handling instrumentation. Packard automated liquid handling solutions from PerkinElmer eliminate the challenge of obsolescence for laboratories by providing modular and scalable solutions to meet their needs now and in the future.
“Today’s laboratories are choosing complete, integrated application platforms to increase their flexibility, precision, and accuracy,” said Jonathan Rennert, Vice President and General Manager, Analytical Sciences, for PerkinElmer’s Life and Analytical Sciences division. “Our new enhanced JANUS platform represents a significant opportunity for PerkinElmer to deliver one comprehensive, scalable platform with extended adaptability and functionality to meet our customers’ needs for complete assay automation.”
The JANUS Automated Workstation platform is comprised of a wide selection of solutions, including three new offerings:
- JANUS MDT Automated Workstation – A 96- or 384- channel workstation offering Modular Dispense Technology (MDT) with interchangeable dispense heads, including the proprietary NanoHead™ enabling assay miniaturization with 384-tip processing down to 50 nL with coefficients of variation better than 13 percent. MDT allows customers to automatically program the selection of numerous dispense heads and formats to provide hands-off, “on the fly” adaptability in dynamic volume range and microplate densities up to 1536 wells.
- Gripper Integration Platform – A third arm labware movement option, available on most versions of JANUS, provides comprehensive labware movement within the JANUS deck, as well as to external devices, including plate readers and shakers.
- Mini-JANUS Automated Workstation – Offers a single arm option with a smaller nine position deck that includes the unique MDT interchangeable pipetting head system for automated pipetting into 96-, 384-, and 1536-well microplates.
Key end-user advantages of the comprehensive, integrated JANUS platform include:
- Adaptability – JANUS offers the addition and replacement of liquid handling and labware movement functionality as application and throughput demands evolve. Also, the platform allows for up to three arms for dispensing and labware movement, with full upgradeability to address initial and future requirements.
- Flexibility – The new JANUS Automated Workstation employs a modular design that delivers real-time and future adaptability in throughput, capacity, and dynamic volume range. In addition, JANUS provides laboratories with the ability to treat each sample uniquely.
- Precision – JANUS includes 4- and 8-tip pipetting capability plus 96- or 384-tip MDT dispense head options in a single platform for optimal precision pipetting and performance.
For more information on the JANUS Automated Workstation, please visit: www.perkinelmer.com/JANUS.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," “projects,” “forecasts,” "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our ability to identify a purchaser of the Company’s semiconductor business, negotiate and consummate the sale of such business, including obtaining regulatory approvals; (2) economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries; (3) risks related to our failure to introduce new products in a timely manner; (4) our ability to comply with financial covenants contained in our credit agreements and our debt instruments; (5) a delay in resolution of the Company’s tax audits and an adverse determination with respect to the Company’s tax audits by the Internal Revenue Service or other taxing authorities; (6) cyclical downturns continuing to affect several of the industries into which we sell our products; (7) our ability to adjust our operations to address unexpected changes; (8) our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business; (9) the loss of any of our licenses that may require us to stop selling products or lose competitive advantage; (10) competition; (11) regulatory compliance; (12) regulatory changes; (13) our failure to obtain and enforce intellectual property protection; (14) our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets; (15) other factors which we describe under the caption "Forward-Looking Information and Factors Affecting Future Performance" in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
Other Information
Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging. Photonics markets include sensors and specialty lighting.